Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells.

Yang J, Zhang Z, Zhang Y, Ni X, Zhang G, Cui X, Liu M, Xu C, Zhang Q, Zhu H, Yan J, Zhu VF, Luo Y, Hagan JP, Li Z, Fang J, Jatoi A, Fernandez-Zapico ME, Zheng L, Edil BH, Bronze MS, Houchen CW, Li YP, Li M.

Gastroenterology. 2019 Feb;156(3):722-734.e6. doi: 10.1053/j.gastro.2018.10.026. Epub 2018 Oct 17.

PMID:
30342032
2.

ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism.

Liu M, Yang J, Zhang Y, Zhou Z, Cui X, Zhang L, Fung KM, Zheng W, Allard FD, Yee EU, Ding K, Wu H, Liang Z, Zheng L, Fernandez-Zapico ME, Li YP, Bronze MS, Morris KT, Postier RG, Houchen CW, Yang J, Li M.

Clin Cancer Res. 2018 Jul 1;24(13):3186-3196. doi: 10.1158/1078-0432.CCR-18-0263. Epub 2018 Apr 3.

3.

Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.

Ge Y, Weygant N, Qu D, May R, Berry WL, Yao J, Chandrakesan P, Zheng W, Zhao L, Zhao KL, Drake M, Vega KJ, Bronze MS, Tomasek JJ, An G, Houchen CW.

Int J Cancer. 2018 Sep 1;143(5):1162-1175. doi: 10.1002/ijc.31400. Epub 2018 Apr 16.

4.

Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injury.

Chandrakesan P, May R, Weygant N, Qu D, Berry WL, Sureban SM, Ali N, Rao C, Huycke M, Bronze MS, Houchen CW.

Sci Rep. 2016 Nov 23;6:37667. doi: 10.1038/srep37667.

5.

Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells.

Chandrakesan P, Panneerselvam J, Qu D, Weygant N, May R, Bronze MS, Houchen CW.

J Carcinog Mutagen. 2016 Apr;7(2). pii: 257. Epub 2016 Mar 7.

6.

(Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression.

Nguyen CB, Kotturi H, Waris G, Mohammed A, Chandrakesan P, May R, Sureban S, Weygant N, Qu D, Rao CV, Dhanasekaran DN, Bronze MS, Houchen CW, Ali N.

Cancer Res. 2016 Aug 15;76(16):4887-96. doi: 10.1158/0008-5472.CAN-15-2722. Epub 2016 Jun 10.

7.

Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase.

Weygant N, Ge Y, Qu D, Kaddis JS, Berry WL, May R, Chandrakesan P, Bannerman-Menson E, Vega KJ, Tomasek JJ, Bronze MS, An G, Houchen CW.

Cancer Res. 2016 Jul 15;76(14):4090-9. doi: 10.1158/0008-5472.CAN-16-0029. Epub 2016 Jun 10.

8.

Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal.

Chandrakesan P, May R, Qu D, Weygant N, Taylor VE, Li JD, Ali N, Sureban SM, Qante M, Wang TC, Bronze MS, Houchen CW.

Oncotarget. 2015 Oct 13;6(31):30876-86. doi: 10.18632/oncotarget.5129.

9.

Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases.

Ali N, Chandrakesan P, Nguyen CB, Husain S, Gillaspy AF, Huycke M, Berry WL, May R, Qu D, Weygant N, Sureban SM, Bronze MS, Dhanasekaran DN, Houchen CW.

Oncotarget. 2015 Aug 21;6(24):20327-44.

10.

Journey of a strut: from filter to missile.

Kanwar A, Hawkins BM, Jackson RL, Koehler M, Bronze MS.

Am J Med Sci. 2015 Jan;349(1):92-3. doi: 10.1097/MAJ.0000000000000372. No abstract available.

PMID:
25437126
11.

Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism.

Ali N, Allam H, Bader T, May R, Basalingappa KM, Berry WL, Chandrakesan P, Qu D, Weygant N, Bronze MS, Umar S, Janknecht R, Sureban SM, Huycke M, Houchen CW.

PLoS One. 2013 Nov 19;8(11):e80304. doi: 10.1371/journal.pone.0080304. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/fcc840e2-225c-4d71-920d-a1eab7747e19.

12.

Histoplasma infection of aortofemoral bypass graft.

Patel N, Bronze MS.

Am J Med Sci. 2014 May;347(5):421-4. doi: 10.1097/MAJ.0b013e31829aaab7.

PMID:
23928546
13.

Clinical use of anti-TNF therapy and increased risk of infections.

Ali T, Kaitha S, Mahmood S, Ftesi A, Stone J, Bronze MS.

Drug Healthc Patient Saf. 2013;5:79-99. doi: 10.2147/DHPS.S28801. Epub 2013 Mar 28.

14.

Risk of nocardial infections with anti-tumor necrosis factor therapy.

Ali T, Chakraburtty A, Mahmood S, Bronze MS.

Am J Med Sci. 2013 Aug;346(2):166-8. doi: 10.1097/MAJ.0b013e3182883708. Review.

PMID:
23531994
15.

Primary retroperitoneal abscess caused by Candida glabrata.

Patel BC, Wayangankar SA, Ngo E, Chakrabarty S, Bronze MS.

Am J Med Sci. 2012 Oct;344(4):332-4.

PMID:
22739567
16.

Prophylactic vaccine approach for colon and pancreatic cancers: present and future.

Janakiram NB, Mohammed A, Bronze MS, Rao CV.

Curr Med Chem. 2012;19(22):3664-78. Review.

PMID:
22680926
17.

Warfarin management using point-of-care testing in a university-based internal medicine resident clinic.

Smith M, Harrison D, Ripley T, Grace S, Bronze MS, Jackson R.

Am J Med Sci. 2012 Oct;344(4):289-93.

PMID:
22314105
18.

Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.

Ali N, Allam H, May R, Sureban SM, Bronze MS, Bader T, Umar S, Anant S, Houchen CW.

J Virol. 2011 Dec;85(23):12292-303. doi: 10.1128/JVI.05920-11. Epub 2011 Sep 21.

19.

Refractory hypoxia in an HIV-infected patient--a diagnostic challenge.

Wayangankar SA, Golwala H, Bronze MS.

Am J Emerg Med. 2012 Sep;30(7):1322.e5-6. doi: 10.1016/j.ajem.2011.06.021. Epub 2011 Aug 25.

PMID:
21871757
20.

Southern Society for Clinical Investigation Founders' Medal acceptance.

Bronze MS.

Am J Med Sci. 2011 Aug;342(2):97-8. doi: 10.1097/MAJ.0b013e3182231ce3. No abstract available.

PMID:
21795949
21.

Internal medicine residency redesign.

Weinberger SE, Pereira AG, Iobst WF, Mechaber AJ, Bronze MS.

Ann Intern Med. 2011 Mar 15;154(6):442-3. doi: 10.7326/0003-4819-154-6-201103150-00017. No abstract available.

PMID:
21403084
22.

Competency-based education and training in internal medicine.

Weinberger SE, Pereira AG, Iobst WF, Mechaber AJ, Bronze MS; Alliance for Academic Internal Medicine Education Redesign Task Force II.

Ann Intern Med. 2010 Dec 7;153(11):751-6. doi: 10.7326/0003-4819-153-11-201012070-00009.

PMID:
21135298
23.

Infectious agents of food- and water-borne illnesses.

Fleckenstein JM, Bartels SR, Drevets PD, Bronze MS, Drevets DA.

Am J Med Sci. 2010 Sep;340(3):238-46. doi: 10.1097/MAJ.0b013e3181e99893. Review.

PMID:
20823701
24.

Emerging pathogens and knowledge in infectious diseases.

Greenfield RA, Bronze MS.

Am J Med Sci. 2010 Sep;340(3):177-80. doi: 10.1097/MAJ.0b013e3181e937fe. No abstract available.

PMID:
20697260
25.

Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.

Bronze MS, Dale JB.

Am J Med Sci. 2010 Sep;340(3):218-25. doi: 10.1097/MAJ.0b013e3181e939ab. Review.

26.

Infection caused by Rahnella aquatilis.

Gaitán JI, Bronze MS.

Am J Med Sci. 2010 Jun;339(6):577-9.

PMID:
20545014
27.

Robert Koch and the 'golden age' of bacteriology.

Blevins SM, Bronze MS.

Int J Infect Dis. 2010 Sep;14(9):e744-51. doi: 10.1016/j.ijid.2009.12.003. Epub 2010 Apr 21.

28.

Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis.

Madhoun MF, Fazili J, Bright BC, Bader T, Roberts DN, Bronze MS.

Am J Med Sci. 2010 Feb;339(2):169-73. doi: 10.1097/MAJ.0b013e3181c4af27. Review.

PMID:
20087166
29.

Osteoporosis in inflammatory bowel disease.

Ali T, Lam D, Bronze MS, Humphrey MB.

Am J Med. 2009 Jul;122(7):599-604. doi: 10.1016/j.amjmed.2009.01.022. Review.

30.

Mycobacterium bovis infection of an axillary-femoral bypass graft after intravesical bacille Calmette-Guérin immunotherapy for bladder cancer.

Shakir F, Dang V, Bronze MS, Liu C, Machado L.

Am J Med Sci. 2009 Jan;337(1):63-4. doi: 10.1097/01.MAJ.0000308884.50320.8a.

PMID:
18941407
31.

Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease.

Blevins SM, Greenfield RA, Bronze MS.

Cleve Clin J Med. 2008 Jul;75(7):521-30. Review.

PMID:
18646588
32.

Innate responses to systemic infection by intracellular bacteria trigger recruitment of Ly-6Chigh monocytes to the brain.

Drevets DA, Schawang JE, Dillon MJ, Lerner MR, Bronze MS, Brackett DJ.

J Immunol. 2008 Jul 1;181(1):529-36.

33.

A confusing case of confusion. Acute porphyrias.

Jackson R, Toubia N, Dhaliwal G, Bottomley SS, Bronze MS.

J Okla State Med Assoc. 2008 Apr;101(4):85-6, 89-90. No abstract available.

PMID:
18557584
34.

Listeria monocytogenes: epidemiology, human disease, and mechanisms of brain invasion.

Drevets DA, Bronze MS.

FEMS Immunol Med Microbiol. 2008 Jul;53(2):151-65. doi: 10.1111/j.1574-695X.2008.00404.x. Epub 2008 May 6. Review.

35.

Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation.

Smith BJ, Lightfoot SA, Lerner MR, Denson KD, Morgan DL, Hanas JS, Bronze MS, Postier RG, Brackett DJ.

Cardiovasc Pathol. 2009 Jan-Feb;18(1):1-10. doi: 10.1016/j.carpath.2007.07.011. Epub 2007 Oct 24.

PMID:
18402801
36.

Gatifloxacin-associated hypoglycemia.

Ali T, Greenfield RA, Scofield H, Bronze MS.

J Okla State Med Assoc. 2007 Nov;100(11):425-8.

PMID:
18183859
37.

Part XV. Antiretroviral therapy for human immunodeficiency virus infection.

Stephens JR, Rathbun RC, Lockhart SM, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Nov;100(11):417-24. Review.

PMID:
18183858
38.

Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.

Lockhart SM, Salvaggio MR, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Oct;100(10):388-95.

PMID:
18085096
39.

Part XIII. Systemic antifungal therapy.

Busse KH, Gentry CA, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Sep;100(9):344-51. Review.

PMID:
18020039
40.

Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide.

Sud B, Salvaggio M, Greenfield R, Bronze MS.

J Okla State Med Assoc. 2007 Jul;100(7):267-72. Review. No abstract available. Erratum in: J Okla State Med Assoc. 2007 Oct;100(10):405. Greenfield, Ronald A [corrected to Greenfield, Ronald].

PMID:
17896614
41.

Part X. Tetracycline and glycylcycline antimicrobials.

Vincent S, Bronze MS, Cooper TW, Greenfied RA.

J Okla State Med Assoc. 2007 Jun;100(6):241-7. Review. No abstract available.

PMID:
17708423
42.

Part IX. Quinolone antimicrobials.

Vincent S, Machado L, Cooper TW, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 May;100(5):149-56. Review. No abstract available.

PMID:
17557602
43.

Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides.

Hoffman-Roberts HL, Obritsch MD, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Apr;100(4):105-11. Review. No abstract available.

PMID:
17476993
44.

Part VII. Macrolides, azalides, ketolides, lincosamides, and streptogramins.

Dang V, Nanda N, Cooper TW, Greenfield RA, Bronze MS.

J Okla State Med Assoc. 2007 Mar;100(3):75-81. Review.

PMID:
17432033
45.

Antimicrobial symposium. Part VI. Aminoglycosides and polymyxins.

Nanda N, Dang V, Cooper TW, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Feb;100(2):60-4. No abstract available.

PMID:
17393675
46.

Part V. Other beta-lactam antimicrobials.

Gibbs WJ, Cooper TW, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Jan;100(1):23-5. Review. No abstract available.

PMID:
17378498
47.

Antimicrobial symposium. Part IV. Cephalosporins.

Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2006 Dec;99(12):579-83. Review. No abstract available.

PMID:
17310925
48.

Part III. Penicillins.

Gibbs WJ, Cooper TW, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2006 Nov;99(11):551-6. Review. No abstract available.

PMID:
17191689
49.

Part II. Introduction to the beta-lactam antibiotics.

Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2006 Oct;99(10):516-20. Review. No abstract available.

PMID:
17125105
50.

Antimicrobial symposium. Part 1. Principles of antimicrobial therapy.

Greenfield RA, Cooper TW, Bronze MS.

J Okla State Med Assoc. 2006 Sep;99(9):474-9. Review. No abstract available.

PMID:
17087070

Supplemental Content

Loading ...
Support Center